VICENNATI, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 6.267
NA - Nord America 5.903
EU - Europa 4.363
SA - Sud America 353
AF - Africa 329
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.226
Nazione #
US - Stati Uniti d'America 5.834
VN - Vietnam 2.124
SG - Singapore 1.488
CN - Cina 1.352
IT - Italia 1.223
GB - Regno Unito 747
HK - Hong Kong 525
SE - Svezia 484
DE - Germania 479
FR - Francia 318
IN - India 253
BR - Brasile 252
RU - Federazione Russa 211
IE - Irlanda 169
UA - Ucraina 131
FI - Finlandia 114
NL - Olanda 114
JP - Giappone 106
KR - Corea 106
ZA - Sudafrica 94
CH - Svizzera 92
TG - Togo 85
EE - Estonia 63
CI - Costa d'Avorio 58
BG - Bulgaria 44
PH - Filippine 42
AR - Argentina 41
BE - Belgio 37
SC - Seychelles 37
IQ - Iraq 36
CA - Canada 35
BD - Bangladesh 32
AT - Austria 30
ID - Indonesia 29
JO - Giordania 28
TH - Thailandia 28
PL - Polonia 26
NG - Nigeria 23
MX - Messico 22
TR - Turchia 22
TW - Taiwan 21
ES - Italia 16
EC - Ecuador 14
SA - Arabia Saudita 13
CL - Cile 12
GR - Grecia 11
UZ - Uzbekistan 11
IR - Iran 10
LT - Lituania 10
PY - Paraguay 10
PK - Pakistan 8
CO - Colombia 7
AU - Australia 6
EG - Egitto 6
MA - Marocco 6
MY - Malesia 6
PE - Perù 6
VE - Venezuela 6
HR - Croazia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
CY - Cipro 3
LB - Libano 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
KE - Kenya 2
MD - Moldavia 2
MU - Mauritius 2
NP - Nepal 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
EU - Europa 1
FJ - Figi 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
Totale 17.211
Città #
Singapore 969
Ashburn 703
Southend 623
Fairfield 553
Hong Kong 484
Ho Chi Minh City 473
Hanoi 436
Bologna 379
Chandler 354
San Jose 317
Woodbridge 248
Seattle 237
Wilmington 237
Santa Clara 224
Hefei 217
Houston 210
Ann Arbor 177
Beijing 174
Princeton 174
Cambridge 172
Dublin 169
Los Angeles 147
Dong Ket 136
Boardman 122
Milan 113
Lauterbourg 102
Helsinki 98
Tokyo 88
Seoul 86
Lomé 85
Jacksonville 80
Da Nang 72
Westminster 72
Haiphong 70
Bern 67
Nanjing 67
Padova 61
New York 60
Abidjan 58
Council Bluffs 58
Dallas 58
Buffalo 57
The Dalles 52
Berlin 47
Shenyang 44
Sofia 43
Turin 41
Jinan 40
Saint Petersburg 40
Guangzhou 39
Redmond 39
Frankfurt am Main 37
Munich 37
San Diego 37
Redondo Beach 35
Amsterdam 33
Bremen 30
Amman 28
Biên Hòa 28
Changsha 28
Chicago 28
Thái Nguyên 28
Brussels 27
Shanghai 26
São Paulo 26
Nanchang 25
Can Tho 24
Florence 24
Orem 23
Hyderabad 22
Johannesburg 22
Redwood City 22
Rome 22
Hải Dương 21
Mülheim 21
Abeokuta 20
Bengaluru 20
Quận Bình Thạnh 20
Vienna 20
Hebei 19
Naples 19
London 18
Medford 18
Tianjin 18
Hangzhou 17
Jakarta 17
Bắc Giang 16
Vũng Tàu 16
Ha Long 15
Warsaw 15
Boydton 14
Phoenix 14
Shenzhen 14
Verona 14
Zhengzhou 14
Atlanta 13
Bến Tre 13
Des Moines 13
Falkenstein 13
Jiaxing 13
Totale 10.729
Nome #
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 331
Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome 314
Pre-operative imaging workup for surgical intervention in primary hyperparathyroidism: A tertiary referral center experience 272
Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score 246
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 232
Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia 232
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma 231
Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study 229
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. 229
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 226
Aldosterone and type 2 diabetes mellitus 226
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 225
Clinical significance of BRAF mutation in thyroid papillary cancer 224
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone 223
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women 221
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism 221
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 218
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma 216
Long-term surgical outcome and impact on daily life activities of strabismus surgery in thyroid-associated ophthalmopathy with and without previous orbital decompression 212
Exploring Attachment Dimensions in Individuals with Overweight or Obesity 210
Food addiction distinguishes an overweight phenotype that can be reversed by low calorie diet 210
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 207
Obituary: Renato Pasquali (1946-2019) 207
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk 205
In memoriam: Renato Pasquali (1946-2019) 200
Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature 196
Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study 196
Monitoring adrenal insufficiency through salivary steroids: a pilot study. 192
A new interaction to come: Ghrelin and steroid hormones 192
Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity 192
Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment 190
Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors 188
Cortisol, energy intake, and food frequency in overweight/obese women 185
Impact of age, body weight and metabolic risk factors on steroid reference intervals in men 184
New insights into the comorbid conditions of Turner syndrome: results from a long-term monocentric cohort study 182
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states 181
Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test 179
The calcium-to-phosphorous (Ca/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study 178
Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC). 178
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 176
The endocannabinoid system and the treatment of obesity. 176
Obesity-related proliferative diseases: The interaction between adipose tissue and estrogens in post-menopausal women 176
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow 174
Relationships between total and regional adiposity and epicardial fat in obese women: how can dual-energy X-ray absorptiometry be associated with echocardiographic epicardial fat measurements? 168
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 167
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. 161
Radiological formula for differentiating between secreting and non secreting adrenal adenomas. 160
Le aree cerebrali ed i neurotrasmettitori deputati al senso di sazietà, piacere e dipendenza: quale ruolo nel mantenimento dell'obesità? 158
A step towards a multidisciplinary interpretative algorithm for indeterminate adrenal lesions: the value of visual and semi-quantitative 18F-FDG PET/CT and ceCT parameters 158
Circulating obestatin levels and the grelin/obestatin ratio in obese women 156
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. 156
DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas 154
La surrenectomia laparoscopica: le dimensioni della lesione costituiscono un limite all'approccio mini-invasivo? 153
Stress-related development of obesity and cortisol in women 153
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. 153
Radiological formula for differentiating between secreting and non secreting adrenal adenomas. 153
Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease 147
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. 147
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors 144
The learning curve for the second generation of laparoscopic surgeons: lesson learned from a large series of laparoscopic adrenalectomies 144
Formula radiologica per differenziare adenomi surrenalici secernenti e non secernenti 141
Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity. 140
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 139
Expression of the different components of the endocannabinoid system (ECs) in morbid obesity. 138
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS 136
Fisiopatologia del sistema endocannabinoide: focus sul metabolismo 135
Metabolic consequences: Obesity and energy expenditure, can they be treated? 134
Value of immunonutrition in patients undergoing pancreatic resection: a trial sequential meta-analysis 132
Steroids and the metabolic syndrome. 132
Steroid reference intervals in women: influence of menopause, age and metabolism 132
The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. 130
Clinical Significance of BRAF Mutation in Papillary Cancer 129
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series 128
Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity 124
Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter 123
Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study 115
Validation of an LC–MS/MS salivary assay for glucocorticoid status assessment: Evaluation of the diurnal fluctuation of cortisol and cortisone and of their association within and between serum and saliva 115
Glucocorticoids, stress and obesity 114
Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling 114
Phosphate Metabolism and Pathophysiology in Parathyroid Disorders and Endocrine Tumors 113
Steroid profiling by LC-MS/MS in nonsecreting and subclinical cortisol-secreting adrenocortical adenomas 111
The endocannabinoid system, energy expenditure and thermogenesis 110
WCN23-0462 DIABETIC KIDNEY DISEASE: A COMPARISON OF SELECTED COHORTS OF PATIENTS FROM LOW-MIDDLE AND HIGH INCOME COUNTRIES 110
Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology 109
Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. 106
How many sites of action for endocannabinoids to control energy metabolism? 106
Epicardial Fat assessed bydual-energy X-ray absorptiometry 105
Endocrine determinants of fat distribution 104
The endocannabinoid system in the regulation of cardiometabolic risk factots 104
The unrelenting fall of the pharmacological treatment of obesity 103
Il sistema endocannabinoide. Nuovo target terapeutico per fronteggiare l'obesità addominale e le sue comorbidità 102
Involvement of the endocannabinoid system in metabolism and fertility 101
Nutrition and polycistic ovary syndrome 99
Relationship between cortisol, energy intake and food frequency in overweight/obese women 97
Feeding Disorders and Obesity 96
null 96
La terapia farmacologica dell'obesità 95
Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia [Endocannabinoid system and energy metabolism: physiology and pathophysiology] 94
Secondary hyperaldosteronism and liver fibrosis in patients with compensated chronic liver disease or portal hypertension 88
La terapia farmacologica dell'obesità [Pharmacological therapy of obesity] 87
Totale 16.301
Categoria #
all - tutte 46.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021567 0 0 0 0 0 0 0 0 0 79 56 432
2021/20221.697 89 56 105 109 135 96 39 141 64 154 440 269
2022/20231.912 176 244 90 263 133 132 60 76 316 151 146 125
2023/2024790 78 117 55 49 65 129 46 60 32 78 54 27
2024/20252.504 102 312 290 180 374 146 192 93 48 156 139 472
2025/20266.624 1.053 575 516 449 641 376 995 203 1.352 464 0 0
Totale 17.533